COMP <GO>
CMPR vs PG // REVENUE GROWTH (YOY)
Cimpress plc (Ireland) (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: CMPR 3
— PG 10
▲ REVENUE GROWTH (YOY) LEADER: CMPR
LAST: $60.32 (-19.35%) • MKT CAP: $1.49B
revenue-growth
3.40%
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
revenue-growth
0.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CMPR VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CMPR | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 47.50% | 51.20% | -3.70 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.70% | 25.40% | -2.70 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.3x | 16.2x | -6.90 | CMPR | /valuation <GO> |
| Free Cash Flow Yield | 14.08% | 3.77% | +10.31 | CMPR | /fcf-yield <GO> |
| Operating Margin | 6.60% | 24.30% | -17.70 | PG | /operating-margins <GO> |
| Net Profit Margin | 0.40% | 19.00% | -18.60 | PG | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 3.40% | 0.30% | +3.10 | CMPR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.34 | 5.59 | -3.25 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.6 | 60.3 | -31.70 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 92.3x | 21.7x | +70.60 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.49B | $372.21B | -$370.73B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CMPR REV | PG REV | CMPR GROSS % | PG GROSS % | CMPR FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.40B | $84.28B | 47.5% | 51.2% | $209.0M | $14.04B |
| FY 2024 | $3.29B | $84.04B | 48.5% | 51.4% | $295.8M | $16.52B |
| FY 2023 | $3.08B | $82.01B | — | — | $130.3M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CMPR // BETA —
PG // BETA 0.87